LIVE FROM THE DATABASETRANSACTIONS 548,563COMPANIES 6,307LATEST TRADE Oct 16UPDATED Oct 18, 12:14 AM
YMABCIK 0001722964

Y-mAbs Therapeutics, Inc.

13 transactions by 6 insiders, from January 17, 2025 to March 7, 2025.

Transactions
136 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
$77Kopen market
Net
−$77Knet selling

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Thomas GadChief3——$57K
Rossi Michael JCEO3——$20K
PFREUNDSCHUH PETER P.CFO2———
LaRocca JohnGC2———
Wilms JorisCOO2———
Douglas J. GentilcoreSVP1———

All transactions

13 in total, newest filings first.

InsiderDateCodeSharesPriceValueHeld after
Rossi Michael JCEOMar 7S3,917$5.20$20K137,083
Thomas GadChiefMar 7S10,810$5.23$57K202,721
Wilms JorisCOODERIVJan 17A42,900$0.00—?42,900derivatives
Wilms JorisCOOJan 17A21,500$0.00—52,100
Rossi Michael JCEODERIVJan 17A210,700$0.00—?210,700derivatives
Rossi Michael JCEOJan 17A105,300$0.00—141,000
PFREUNDSCHUH PETER P.CFODERIVJan 17A63,500$0.00—?63,500derivatives
PFREUNDSCHUH PETER P.CFOJan 17A31,800$0.00—77,800
LaRocca JohnGCDERIVJan 17A42,900$0.00—?42,900derivatives
LaRocca JohnGCJan 17A21,500$0.00—21,500
Douglas J. GentilcoreSVPDERIVJan 17A142,600$0.00—?142,600derivatives
Thomas GadChiefDERIVJan 17A64,000$0.00—?64,000derivatives
Thomas GadChiefJan 17A32,000$0.00—213,531